These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8609241

  • 1. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
    Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett TA, Sayegh MH.
    J Clin Invest; 1996 Feb 01; 97(3):833-8. PubMed ID: 8609241
    [Abstract] [Full Text] [Related]

  • 2. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 01; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 3. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH.
    Proc Natl Acad Sci U S A; 1996 Oct 29; 93(22):12439-44. PubMed ID: 8901600
    [Abstract] [Full Text] [Related]

  • 4. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.
    Tikkanen JM, Lemström KB, Koskinen PK.
    Am J Respir Crit Care Med; 2002 Mar 01; 165(5):724-9. PubMed ID: 11874822
    [Abstract] [Full Text] [Related]

  • 5. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
    Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH.
    Transplantation; 1997 Apr 27; 63(8):1053-8. PubMed ID: 9133464
    [Abstract] [Full Text] [Related]

  • 6. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.
    Chandraker A, Azuma H, Nadeau K, Carpenter CB, Tilney NL, Hancock WW, Sayegh MH.
    J Clin Invest; 1998 Jun 01; 101(11):2309-18. PubMed ID: 9616202
    [Abstract] [Full Text] [Related]

  • 7. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H, Wei RQ, Goodman RE, Bolling SF.
    Surgery; 1997 Aug 01; 122(2):129-37. PubMed ID: 9288115
    [Abstract] [Full Text] [Related]

  • 8. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF, Lin H, Wei RQ, Turka LA.
    J Heart Lung Transplant; 1996 Sep 01; 15(9):928-35. PubMed ID: 8889989
    [Abstract] [Full Text] [Related]

  • 9. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH.
    Transplantation; 1996 Dec 27; 62(12):1942-5. PubMed ID: 8990393
    [Abstract] [Full Text] [Related]

  • 10. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832
    [Abstract] [Full Text] [Related]

  • 11. Soluble CTLA4Ig modifies parameters of acute inflammation in rat lung allograft rejection without altering lymphocytic infiltration or transcription of key cytokines.
    Matsumura Y, Zuo XJ, Prehn J, Linsley PS, Marchevsky A, Kass RM, Matloff JM, Jordan SC.
    Transplantation; 1995 Feb 27; 59(4):551-8. PubMed ID: 7533346
    [Abstract] [Full Text] [Related]

  • 12. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
    Glysing-Jensen T, Räisänen-Sokolowski A, Sayegh MH, Russell ME.
    Transplantation; 1997 Dec 27; 64(12):1641-5. PubMed ID: 9422395
    [Abstract] [Full Text] [Related]

  • 13. The time course of CTLAIg effect on cardiac allograft rejection.
    Bolling SF, Lin H, Turka LA.
    J Surg Res; 1996 Jun 27; 63(1):320-3. PubMed ID: 8661218
    [Abstract] [Full Text] [Related]

  • 14. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
    Séveno C, Coulon F, Haspot F, Mérieau E, Renaudin K, Martinet B, Vanhove B.
    Xenotransplantation; 2007 Jan 27; 14(1):25-33. PubMed ID: 17214702
    [Abstract] [Full Text] [Related]

  • 15. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
    Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA.
    J Exp Med; 1995 May 01; 181(5):1869-74. PubMed ID: 7536798
    [Abstract] [Full Text] [Related]

  • 16. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1999 Jul 27; 68(2):288-93. PubMed ID: 10440403
    [Abstract] [Full Text] [Related]

  • 17. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
    Schaub M, Stadlbauer TH, Chandraker A, Vella JP, Turka LA, Sayegh MH.
    J Am Soc Nephrol; 1998 May 27; 9(5):891-8. PubMed ID: 9596088
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A, Tu Y, Arima T, Linsley PS, Flye MW.
    Surgery; 1996 Aug 27; 120(2):205-12. PubMed ID: 8751584
    [Abstract] [Full Text] [Related]

  • 19. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
    Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA.
    J Exp Med; 1993 Nov 01; 178(5):1801-6. PubMed ID: 8228826
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.